How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

903 results for

Seborrheic Dermatitis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Pimecrolimus for the Treatment of Adults with Atopic Dermatitis, Seborrheic Dermatitis, or Psoriasis: A Review of Clinical and Cost-Effectiveness

Pimecrolimus for the Treatment of Adults with Atopic Dermatitis, Seborrheic Dermatitis, or Psoriasis: A Review of Clinical and Cost-Effectiveness Pimecrolimus for the Treatment of Adults with Atopic Dermatitis, Seborrheic Dermatitis, or Psoriasis: A Review of Clinical and Cost-Effectiveness | CADTH.ca Find the information you need Pimecrolimus for the Treatment of Adults with Atopic Dermatitis, Seborrheic Dermatitis, or Psoriasis: A Review of Clinical and Cost-Effectiveness Pimecrolimus (...) for the Treatment of Adults with Atopic Dermatitis, Seborrheic Dermatitis, or Psoriasis: A Review of Clinical and Cost-Effectiveness Published on: September 25, 2017 Project Number: RC0919-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of pimecrolimus for the treatment of adults with atopic dermatitis? What is the clinical effectiveness of pimecrolimus for the treatment of adults with seborrheic dermatitis? What

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

2. Seborrhoeic dermatitis

Seborrhoeic dermatitis Seborrhoeic dermatitis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Seborrhoeic dermatitis Last reviewed: February 2019 Last updated: October 2018 Summary Chronic inflammatory skin disorder characterised by erythematous and greasy scaly patches. Patches are red, inflamed, and pruritic with micaceous scale. Circumscribed patches are found on the scalp, glabella, nasolabial fold, posterior (...) auricular skin, and anterior chest. Variable course that seldom completely subsides. An infant form (cradle cap) usually resolves within the first few months of life. Tends to flare with stress. The adult scalp form is commonly termed dandruff or pityriasis capitis. Topical agents (corticosteroids, antifungals, calcineurin inhibitors, shampoos, and tar preparations) are used for mild and limited disease. Oral antifungals are reserved for severe and recalcitrant forms. Definition Seborrhoeic dermatitis

2018 BMJ Best Practice

3. Seborrhoeic dermatitis

Seborrhoeic dermatitis Seborrhoeic dermatitis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Seborrhoeic dermatitis Last reviewed: February 2019 Last updated: October 2018 Summary Chronic inflammatory skin disorder characterised by erythematous and greasy scaly patches. Patches are red, inflamed, and pruritic with micaceous scale. Circumscribed patches are found on the scalp, glabella, nasolabial fold, posterior (...) auricular skin, and anterior chest. Variable course that seldom completely subsides. An infant form (cradle cap) usually resolves within the first few months of life. Tends to flare with stress. The adult scalp form is commonly termed dandruff or pityriasis capitis. Topical agents (corticosteroids, antifungals, calcineurin inhibitors, shampoos, and tar preparations) are used for mild and limited disease. Oral antifungals are reserved for severe and recalcitrant forms. Definition Seborrhoeic dermatitis

2018 BMJ Best Practice

6. Topical Application of 5-Fluorouracil Associated with Distant Seborrheic Dermatitis-like Eruption: Case Report and Review of Seborrheic Dermatitis Cutaneous Reactions after Systemic or Topical Treatment with 5-Fluorouracil Full Text available with Trip Pro

Topical Application of 5-Fluorouracil Associated with Distant Seborrheic Dermatitis-like Eruption: Case Report and Review of Seborrheic Dermatitis Cutaneous Reactions after Systemic or Topical Treatment with 5-Fluorouracil 5-Fluorouracil is a fluoropyrimidine antineoplastic medication that is used to topically treat actinic keratoses. Although local adverse effects to the drug are common and anticipated, distant skin reactions are rare and unexpected. In this case report, we describe a patient (...) who developed seborrheic dermatitis-like eruption at a distant site after topical application of 5-fluorouracil to his arms.A 63-year-old man with actinic keratoses on his arms developed a facial seborrheic dermatitis-like reaction after topically applying 5-fluorouracil 5% cream twice daily to actinic keratoses on his forearms for 7 days. The facial dermatosis resolved shortly after discontinuation of the 5-fluorouracil; upon rechallenge of topical 5-fluorouracil on his arms, the facial

2018 Dermatology and therapy

7. Seborrhoeic dermatitis

of seborrhoeic dermatitis. Search dates January 2013 - January 2019 Key search terms The terms listed below are the core search terms that were used for EBSCO host MEDLINE (searched 29th January 2019). The strategy was adapted for The Cochrane Library databases. S4 S1 OR S2 OR S3 S3 AB cradle cap OR TI cradle cap S2 AB ( ((seborrhoeic or seborrheic) N2 (dermati* or eczema*)) ) OR TI ( ((seborrhoeic or seborrheic) N2 (dermati* or eczema*)) ) S1 (MH "Dermatitis, Seborrheic") Sources of guidelines Medline (...) Seborrhoeic dermatitis Seborrhoeic dermatitis - NICE CKS Share Seborrhoeic dermatitis: Summary Seborrhoeic dermatitis is a common inflammatory skin condition occurring in areas rich in sebaceous glands (such as the scalp, nasolabial folds, eyebrows, and chest). In infants the scalp is most commonly affected ('cradle cap'). It typically presents as erythematous patches with scale which may be white or yellow, oily or dry. The exact cause of seborrhoeic dermatitis is not fully understood; many

2019 NICE Clinical Knowledge Summaries

8. Comparison of efficacy and safety of atorvastatin 5% lotion and betamethasone 0.1% lotion in the treatment of scalp seborrheic dermatitis. Full Text available with Trip Pro

Comparison of efficacy and safety of atorvastatin 5% lotion and betamethasone 0.1% lotion in the treatment of scalp seborrheic dermatitis. Purpose: Seborrheic dermatitis (SD) is a chronic inflammatory skin disorder that mainly affects areas rich in sebaceous glands, such as the scalp. Although the exact cause of SD is not clearly understood, it seems that skin colonization with Malassezia fungus and the inflammatory responses of the immune system to this fungus play an important role (...) group received atorvastatin 5% lotion and the betamethasone group received betamethasone 0.1% lotion daily for 4 weeks. The SD severity of each patient was determined by Symptom Scale of Seborrheic Dermatitis (SSSD) at baseline and 4 weeks after treatment. Also, the patient's satisfaction of the treatment and adverse effects were investigated through individual reporting. Results: After 4 weeks of treatment, the score of SD severity decreased significantly in both groups, while changes of SSSD score

2019 Clinical, cosmetic and investigational dermatology Controlled trial quality: uncertain

9. Efficacy and tolerability of 1% ciclopirox shampoo in the treatment of moderate-to-severe scalp seborrheic dermatitis: a multicenter, prospective, assessor-blinded trial. (Abstract)

Efficacy and tolerability of 1% ciclopirox shampoo in the treatment of moderate-to-severe scalp seborrheic dermatitis: a multicenter, prospective, assessor-blinded trial. Seborrheic dermatitis (SD) is a very common inflammatory skin disease. It occurs in 1-3% of the population. The most supported pathogenetic theory links SD to dandruff via a common etiology, yeasts of the genus Malassezia. Ketoconazole and ciclopirox (CPX) shampoo are considered as the first line treatment of SD of the scalp

2019 Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia Controlled trial quality: uncertain

10. Seborrheic dermatitis-Looking beyond Malassezia. Full Text available with Trip Pro

Seborrheic dermatitis-Looking beyond Malassezia. Seborrhoeic Dermatitis (SD) is a very common chronic and/or relapsing inflammatory skin disorder whose pathophysiology remains poorly understood. Yeast of the genus Malassezia has long been regarded as a main predisposing factor, even though causal relationship has not been firmly established. Additional predisposing factors have been described, including sebaceous activity, host immunity (especially HIV infection), epidermal barrier integrity

2019 Experimental Dermatology

11. Epidemiology and Dermatological Comorbidity of Seborrhoeic Dermatitis - Population-based Study in 161,000 Employees. (Abstract)

Epidemiology and Dermatological Comorbidity of Seborrhoeic Dermatitis - Population-based Study in 161,000 Employees. Seborrhoeic dermatitis (SD) is a common but epidemiologically poorly researched chronic skin disease.To characterise the prevalence and dermatological comorbidity of SD in Germany.In the course of voluntary company skin checks, full body examinations were carried out in more than 500 companies by experienced dermatologists and documented electronically.161,269 participants were (...) relative dermatological comorbidity when controlling for age and gender: folliculitis (OR 2.1, 95% CI 2.0-2.3), contact dermatitis (OR 1.8, 95% CI 1.1-2.8), intertriginous dermatitis (OR 1.8, 95% CI 1.4-2.2), rosacea (OR 1.6, 95% CI 1.4-1.8), acne (OR 1.4, 95% CI 1.2-1.7), pyoderma (OR 1.4, 95% CI 1.1-1.8), tinea corporis (OR 1.4, 95% CI 1.0-2.0), pityriasis versicolor (OR 1.3, 95% CI 1.0-1.7) and psoriasis (OR 1.2, 95% CI 1.0-1.4).SD is a common disease which is more prevalent in men and older people

2019 British Journal of Dermatology

12. Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis. (Abstract)

Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis. Pimecrolimus 1% cream has already been proved to be an effective and safe alternative to treat seborrheic dermatitis. However, the treatment periods were inconstant in previous studies.To evaluate the comparative efficacy of pimecrolimus 1% cream with different regimens for the treatment of facial seborrheic dermatitis.Thirty patients with facial seborrheic dermatitis were enrolled (...) be applied twice a day for 4 weeks to treat seborrheic dermatitis.© 2017 Wiley Periodicals, Inc.

2018 Journal of cosmetic dermatology Controlled trial quality: uncertain

13. Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis

Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Omiganan (...) Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03688971 Recruitment Status : Recruiting First Posted : September 28, 2018 Last Update Posted : January 8

2018 Clinical Trials

14. Increased IL17-expressing γδ T Cells in Seborrheic Dermatitis-like Lesions of the Mpzl3 Knockout Mice. (Abstract)

Increased IL17-expressing γδ T Cells in Seborrheic Dermatitis-like Lesions of the Mpzl3 Knockout Mice. Seborrhoeic Dermatitis (SD) is a common inflammatory skin disorder, but its molecular pathogenesis remains elusive. Previously, we have established the Mpzl3 knockout (-/-) mice as a model for SD. In this study, we focused on early phases of skin inflammation and determined the cytokine profiles and identified immune cell types in the lesional skin in the Mpzl3 -/- mice. Using flow cytometry

2018 Experimental Dermatology

15. Association between diet and seborrheic dermatitis: a cross-sectional study. Full Text available with Trip Pro

Association between diet and seborrheic dermatitis: a cross-sectional study. Current treatments for seborrheic dermatitis provide only temporary relief. Therefore, identifying modifiable lifestyle factors may help reduce disease burden. The objective of this study was to determine whether specific dietary patterns or total antioxidant capacity are associated with seborrheic dermatitis. Participants of the Rotterdam Study with a skin examination and a food frequency questionnaire were included (...) . Total antioxidant capacity was assessed on the basis of ferric reducing antioxidant potential of each food item. Dietary patterns were identified with principal component analysis (PCA). Multivariable logistic regression analyses were used to assess the association between total antioxidant capacity, dietary pattern-derived PCA factors, and seborrheic dermatitis adjusted for confounders. In total, 4,379 participants were included, of whom 636 (14.5%) had seborrheic dermatitis. The PCA identified

2018 Journal of Investigative Dermatology

16. Progressive Facial Papules in an African-American Patient: An Atypical Presentation of Seborrheic Dermatitis Full Text available with Trip Pro

Progressive Facial Papules in an African-American Patient: An Atypical Presentation of Seborrheic Dermatitis This case report highlights a unique variant of seborrheic dermatitis (SD) in a 30-year-old African-American woman with progressive facial papules. Four weeks of uninterrupted mild potency topical corticosteroid therapy produced marked improvement of signs and symptoms of biopsy-confirmed SD. SD mimicking cutaneous sarcoidosis is a unique treatment-responsive variant of SD that may

2018 The Journal of clinical and aesthetic dermatology

17. Staphylococcus aureus is the most common bacterial agent of the skin flora of patients with seborrheic dermatitis Full Text available with Trip Pro

Staphylococcus aureus is the most common bacterial agent of the skin flora of patients with seborrheic dermatitis Seborrheic dermatitis is an inflammatory skin disease that affects 1-3% of the general population. The Malassezia species has been implicated as the main causative agent; however, the bacterial flora of the skin may also play role in the etiopathogenesis. Therefore, we investigated the most common bacterial agent of the skin flora of patients with seborrheic dermatitis.Fifty-one (...) patients with seborrheic dermatitis and 50 healthy individuals are included in this study. Sterile cotton swabs were rubbed on the scalp of the participants for bacterial culture. Colonial morphology was identified with gram stain and catalase test.Staphylococcus aureus was isolated from 25 (49%) patients with seborrheic dermatitis and 10 (20%) healthy individuals within the control group. Coagulase-negative staphylococci were isolated from 24 (47.1%) patients with seborrheic dermatitis and 17 (34

2018 Dermatology practical & conceptual

18. Scalp Seborrheic Dermatitis and Dandruff Therapy Using a Herbal and Zinc Pyrithione-based Therapy of Shampoo and Scalp Lotion Full Text available with Trip Pro

Scalp Seborrheic Dermatitis and Dandruff Therapy Using a Herbal and Zinc Pyrithione-based Therapy of Shampoo and Scalp Lotion Objective: The aim of this study was to evaluate the safety and efficacy of an herbal and zinc pyrithione shampoo and a scalp lotion (Kamedis Derma-Scalp Dandruff Therapy, Kamedis Ltd., Tel Aviv, Israel) for the treatment of scalp seborrheic dermatitis and dandruff. Design: This was an interventional, open-label, safety and efficacy study. Setting: This open-label study (...) was conducted at Consumer Product Testing Company Inc. in Fairfield, New Jersey. At the baseline visit (Day 0), an examination of the scalp was conducted by a board-certified dermatologist. The entire scalp was evaluated for evidence of seborrheic dermatitis using the Adherent Scalp Flaking Score with a 10-point scale. Only subjects with evidence of moderate-to-greater seborrheic dermatitis or moderate-to-greater dandruff were deemed qualified for inclusion in the study. Participants: Fifty subjects were

2018 The Journal of clinical and aesthetic dermatology

19. Treatment of Seborrheic Dermatitis: A Comprehensive Review. (Abstract)

Treatment of Seborrheic Dermatitis: A Comprehensive Review. Seborrheic dermatitis (SD) is a chronic, recurring inflammatory skin disorder that manifests as erythematous macules or plaques with varying levels of scaling associated with pruritus. The condition typically occurs as an inflammatory response to Malassezia species and tends to occur on seborrheic areas, such as the scalp, face, chest, back, axilla, and groin areas. SD treatment focuses on clearing signs of the disease; ameliorating

2018 Journal of Dermatological Treatment

20. Malassezia species retrieved from skin with pityriasis versicolor, seborrheic dermatitis and skin free of lesions: a comparison of two sampling methods. (Abstract)

Malassezia species retrieved from skin with pityriasis versicolor, seborrheic dermatitis and skin free of lesions: a comparison of two sampling methods. 29505089 2018 08 24 1365-2133 179 2 2018 Aug The British journal of dermatology Br. J. Dermatol. Malassezia species retrieved from skin with pityriasis versicolor, seborrhoeic dermatitis and skin free of lesions: a comparison of two sampling methods. 526-527 10.1111/bjd.16521 Pedrosa A F AF http://orcid.org/0000-0001-5969-0235 Division

2018 British Journal of Dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>